Use of probiotics in the management of chemotherapy-induced diarrhea: A case study

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 5, 2009, Pages 569-570

  Abd El Atti, Samia ^a   Wasicek, Kelley ^a   Mark, Scott ^a   Hegazi, Refaat ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Chemotherapy; Diarrhea; Probiotic

Indexed keywords

CAPECITABINE; LAPATINIB; LOPERAMIDE; PROBIOTIC AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; DEHYDRATION; DIARRHEA; FEMALE; HOSPITALIZATION; HUMAN; INCONTINENCE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DEOXYCYTIDINE; DIARRHEA; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROBIOTICS; QUINAZOLINES;

EID: 69949102968     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607109332004     Document Type: Article

References (5)

1. Schilsky RL Pharmacology and clinical status of capecitabine. Oncology. 2000 ; 14: 1297-1306.
2. Cruzan S. FDA approves Tykerb for advanced breast cancer patients. March 13, 2007. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01586. Accessed June 5, 2008.
3. Sartor RB, Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep. 2007 ; 9: 497-507.
4. de Moreno de LeBlanc A., Matar C., Perdigen G. The application of probiotics in cancer. Br J Nutr. 2007 ; 98 (Suppl 1). S105 - S110.
5. Osterlund P., Ruotsalainen T., Korpela R., et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 2007 ; 97: 1028-1034.